Skip to content

ACRYSOF® ACRYSERT® SN6CWS (REF SN6CWS.270)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof(R) IQ ASPHERIC IOL, SP ACRYLIC FOLDABLELENS, w/AcrySert(R) DELIVERY SYSTEM, UV w/BLUELIGHT FILTER, 13.0mm LENGTH, 6.0mm ANTERIORASYMMETRIC BICONVEX OPTIC, PLANAR HAPTICS. · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652249355), received between Jul 15, 2022 and Jul 15, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Device Damaged by Another Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Damaged by Another Device1
  • Failure to Eject1
  • Material Split, Cut or Torn1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 15, 2022Device Damaged by Another Device; Material Split, Cut or Torn; Failure to Eject; Device Damaged by Another Device; Material Split, Cut or Torn; Failure to Eject

    A GOVERNMENT AGENCY REPORTED THAT DURING A CATARACT EXTRACTION WITH INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE ONE HAPTIC OF IOL WAS NOT FOLDED AS USUAL, THE IOL WAS ROTATED AS A WHOLE DURING INJECTING AND THE IOL WAS STUCK IN THE TIP OF THE INJECTOR. WHEN THE IOL WAS PUSHED IN TO THE PATIENT¿S ANTERIOR CHAMBER, THE STUCK HAPTIC WAS BROKEN AND DISSOCIATION, THE OTHER HAPTIC WAS SLIGHTLY TORN WITH THE OPTIC, AND THE DISSOCIATION HAPTIC WAS REMOVED AND THE EYE WAS BANDAGED AFTER APPLYING THE MIOTIC MEDICINE. ON THE SECOND DAY AFTER THE OPERATION, THE LENS WAS IN PLACE AND THE SLIGHTLY TORN PART WAS NOT IN OPTIC AND THE PUPIL WAS MIOSIS. THE PATIENT HAD NO HEADACHE, DIZZINESS, EYE PAIN, NAUSEA AND VOMITING SYMPTOMS. THE PATIENT HAD NO DISCOMFORT IN THE FOLLOW-UP VISIT ONE WEEK LATER. NO FURTHER INFORMATION AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15028192 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page